We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

189 hedge funds and large institutions have $1.91B invested in Heron Therapeutics in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 52 increasing their positions, 64 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more call options, than puts

Call options by funds: $2.94M | Put options by funds: $1.2M

42% more capital invested

Capital invested by funds: $1.34B → $1.91B (+$567M)

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

4% more funds holding

Funds holding: 182 → 189 (+7)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.63% less ownership

Funds ownership: 99.99% → 99.36% (-0.63%)

19% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 64

Holders
189
Holders Change
+7
Holders Change %
+3.85%
% of All Funds
3.34%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
26
Increased
52
Reduced
64
Closed
19
Calls
$2.94M
Puts
$1.2M
Net Calls
+$1.74M
Net Calls Change
+$1.8M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$57.7M
2
BlackRock
BlackRock
New York
+$18.4M
3
ITP
Iron Triangle Partners
Connecticut
+$15M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.38M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.4M

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$42.9M
2
CCM
Consonance Capital Management
New York
-$29.7M
3
KCM
Kensico Capital Management
Connecticut
-$8.03M
4
State Street
State Street
Massachusetts
-$7.45M
5
Fidelity International
Fidelity International
Bermuda
-$7.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
101
Citigroup
New York
$447K +$263K +15,114 +251%
IWM
102
IHT Wealth Management
Illinois
$446K +$159K +9,166 +77%
VF
103
Virtu Financial
New York
$437K +$359K +20,667 New
WMSA
104
Weiss Multi-Strategy Advisers
New York
$425K -$89K -5,121 -20%
YIH
105
Y-Intercept (HK)
Hong Kong
$412K +$336K +19,351 New
ProShare Advisors
106
ProShare Advisors
Maryland
$411K +$151K +8,673 +81%
M&T Bank
107
M&T Bank
New York
$404K – – –
AC
108
Athanor Capital
New York
$400K -$738K -42,435 -69%
DT
109
Diversified Trust
Tennessee
$396K – – –
APP
110
Alpha Paradigm Partners
Illinois
$395K +$324K +18,645 New
William Blair & Company
111
William Blair & Company
Illinois
$392K – – –
Royal Bank of Canada
112
Royal Bank of Canada
Ontario, Canada
$391K -$21.4K -1,231 -6%
PHIMC
113
Private Harbour Investment Management & Counsel
Ohio
$385K -$869 -50 -0.3%
First Trust Advisors
114
First Trust Advisors
Illinois
$380K -$495K -28,496 -61%
RJFSA
115
Raymond James Financial Services Advisors
Florida
$364K +$13.5K +775 +5%
Truist Financial
116
Truist Financial
North Carolina
$348K +$24.3K +1,400 +9%
JMPWA
117
JP Morgan Private Wealth Advisors
California
$335K – – –
Public Employees Retirement Association of Colorado
118
Public Employees Retirement Association of Colorado
Colorado
$326K – – –
CM
119
CM Management
Florida
$317K +$261K +15,000 New
FC
120
FORA Capital
Florida
$313K +$257K +14,801 New
Victory Capital Management
121
Victory Capital Management
Texas
$303K +$12.7K +730 +5%
AB
122
Amalgamated Bank
New York
$290K +$1.34K +77 +0.6%
WG
123
Winton Group
United Kingdom
$288K -$973K -55,990 -80%
Handelsbanken Fonder
124
Handelsbanken Fonder
Sweden
$275K – – –
Bank of Montreal
125
Bank of Montreal
Ontario, Canada
$274K +$143K +8,207 +137%
3 4
5
6 7

HRTX Hedge Fund Activity: Q4 2020 in Review

189 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2020, worth a combined $1.91B — up 42% from $1.34B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new HRTX positions and 19 closed out — a net gain of 7 holders — while 52 added to existing stakes and 64 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $57.7M. The largest seller was Tang Capital Management, exiting entirely with an estimated $42.9M sold.

  • 189 institutional investors held Heron Therapeutics (HRTX) as of Q4 2020, up from 182 in Q3 2020.
  • Funds reported $1.91B of Heron Therapeutics stock for Q4 2020, up 42% quarter-over-quarter.
  • 26 funds opened new Heron Therapeutics positions in Q4 2020 and 19 closed out, a net change of +7 holders.
  • The largest Heron Therapeutics buyer in Q4 2020 was Wellington Management Group, an estimated $57.7M added.
  • The largest Heron Therapeutics seller in Q4 2020 was Tang Capital Management, an estimated $42.9M sold.

Based on aggregated 13F filings for Q4 2020.